View Document Preview and Link Document Date: 2015-04-13 17:45:08 Open Document File Size: 1,46 MB Share Result on Facebook
Company Chugai Seiyaku Kabushiki Kaisha Corp. / Roche Group / Genentech USA Inc. / / Event Product Issues / FDA Phase / Reorganization / / Facility Laboratory Parameters / Laboratory Parameters Rheumatoid Arthritis Neutropenia Treatment / / IndustryTerm healthcare practitioner / healthcare professional using aseptic technique / drug products / / MedicalCondition Systemic Juvenile Idiopathic Arthritis ACTEMRA / sometimes fatal infections / TB / Polyarticular Juvenile Idiopathic Arthritis ACTEMRA / Chest pain / headache / active infection / common cold / herpes zoster / disease modifying antirheumatic drug / serious allergic reactions / hives / common serious infections / urinary tract infection / viral and other infections / Rheumatoid Arthritis / cellulitis / pneumocystosis / active systemic juvenile idiopathic arthritis / Demyelinating Disorders / thrombocytopenia / anaphylaxis / Serious infections / active polyarticular juvenile idiopathic arthritis / hepatitis B / sinus infections / Rheumatoid Arthritis ACTEMRA / tuberculosis infection / kg Systemic Juvenile Idiopathic Arthritis / severe abdominal pain / also called hypertension / severely active rheumatoid arthritis / localized infections / extrapulmonary disease / aspergillosis / hypersensitivity / endemic tuberculosis / hepatitis / experienced flushing / endemic mycoses / infections / sepsis / treatment-related neutropenia / Polyarticular Juvenile Idiopathic Arthritis / pneumonia / latent tuberculosis infection / hypertension / every weight week Polyarticular Juvenile Idiopathic Arthritis / opportunistic infections / recurrent infection / disease / bacterial arthritis / nasopharyngitis / gastroenteritis / scars / Shortness of breath / Carcinogenesis / OF SERIOUS INFECTIONS / acute inflammation / neutropenia / candidiasis / Active tuberculosis / active TB / histoplasmosis / localized disease / certain cancers / Active Hepatic Disease / latent tuberculosis / opportunistic infection / latent infection / allergic reactions / Reported infections / coccidioidomycosis / infection / vomiting ell / increased ALT / Invasive fungal infections / clinically evident hepatic injury / Systemic Juvenile Idiopathic Arthritis / rash / serious infection / tuberculosis / upper respiratory tract infections / / MedicalTreatment intravenous therapy / intravenous infusion / Immunosuppression / biologic therapies / Vaccinations / / Organization RA SJIA / Subcutaneous administration / Administration of Intravenous / DOSAGE AND ADMINISTRATION / FDA / SC Administration / Administration of Subcutaneous / / / Position physician / kg General / General / nurse / / Product SC / Sodium Chloride / Subcutaneous Injection / SC Injection / ACTEMRA injection / PJIA / SJIA / response / / PublishedMedium the Medication Guide / / Technology antibodies / Pharmacokinetics / Pharmacodynamics / / URL www.FDA.gov/medwatch / / SocialTag 
B:8.75” T:8.5” S:8” After Your Infusion Now that your infusion is finished, it is important to keep an eye out for possible serious allergic reactions.